IL-10 has a distinct immunoregulatory effect on naive and active T cell subsets

Journal of Interferon and Cytokine Research

Volumn 27, Issue 12, 2007, Pages 1031-1038

  Ye, Zhenmin ^a   Huang, Hui ^a   Hao, Siguo ^b   Xu, Shulin ^b   Yu, Hong ^a   Van Den Hurk, Sylvia ^a   Xiang, Jim ^a,c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c SASKATCHEWAN CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; FEMALE; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNIZATION; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; OVALBUMIN; RECEPTORS, INTERLEUKIN-10; T-LYMPHOCYTE SUBSETS;

MUS;

EID: 38049003097     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.0144     Document Type: Article

References (35)

1. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989;170:2081-2095.
2. Thompson-Snipes L, Dhar V, Rennick DM. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 1991;173:507-510.
3. Zheng LM, Ojcius DM, Garaud F. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J. Exp. Med. 1996;184:579-584.
4. Berkman N, John M, Chung KF. Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages. J. Immunol. 1995;155:4412-4418.
5. Moore KW, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001;19:683-765.
6. Corinti S, Albanesi C, Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 2001;166:4312-4318.
7. Brossart P, Zobywalski A, Brugger W. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells. Cancer Res. 2000;60:4485-4492.
8. Yang S, Li W, Kong Y. IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis. Clin. Immunol. 2006;121:63-73.
9. (+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunol. Immunother. 2007;56:48-59.
10. Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 1992;148:1143-1148.
11. Taga K, Mostowski H, Tosato G. Human interleukin-10 can directly inhibit T-cell growth. Blood 1993;81:2964-2971.
12. + T cells. J. Exp. Med. 1996;184:19-29.
13. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
14. + T regulatory 1 cells to suppress antitumor immunity. J. Immunol. 2005;175:2931-2937.
15. + regulatory T cells. J. Immunol. 2006;177:896-904.
16. Chen WF, Zlotnik A. IL-10: a novel cytotoxic T cell differentiation factor. J. Immunol. 1991;147:528-534.
17. Cohen SB, Crawley JB, Foxwell BM. Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2. Immunology 1997;92:1-5.
18. Rowbottom AW, Lepper MA, Garland RJ, Corley EG. Interleukin-10-induced CD8 cell proliferation. Immunology 1999;98:80-89.
19. (+) T-cell effector function in situ. Blood 2001;98:2143-2151.
20. + T cells. J. Immunol. 1998;160:3188-3193.
21. + T helper antigen-presenting cells. J. Immunol. 2005;174:7497-7505.
22. Hogquist KA, Jameson SC, Heath WR, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell 1994;76:17-27.
23. Li M, Davey GM, Heath WR. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J. Immunol. 2001;166:6099-6103.
24. Foulds KE, Zenewicz LA, Shedlock DJ, Shen H. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 2002;168:1528-1532.
25. Steinbrink K, Wolfl M, Enk AH. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 1997;159:4772-4780.
26. Yang AS, Lattime EC. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 Tcell responses. Cancer Res. 2003;63:2150-2157.
27. Gad M, Kristensen NN, Kury E, Claesson MH. Characterization of T-regulatory cells, induced by immature dendritic cells, which inhibit enteroantigen-reactive colitis-inducing T-cell responses in vitro and in vivo. Immunology 2004;113:499-508.
28. Beinhauer BG, McBride JM, Jung T. Interleukin 10 regulates cell surface and soluble LIR-2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro. Eur. J. Immunol. 2004;34:74-80.
29. Egen JG, Kuhns MS, Allison JP. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 2002;3:611-618.
30. Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science 1996;271:1734-1736.
31. Sanchez-Fueyo A, Weber M, Zheng XX. Tracking the immunoregulatory mechanisms active during allograft tolerance. J. Immunol. 2002;168:2274-2281.
32. + cells, and the alloreactive T cell clone size. J. Immunol. 2002;169:3744-3751.
33. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 2003;3:199-210.
34. Engelhardt JJ, Sullivan TJ, Allison JP. CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism. J. Immunol. 2006;177:1052-1061.
35. + T cells is facilitated by CTLA-4 signaling. J. Immunol. 2006;177:2331-2339.